MLTA3698A
MLTA3698A Uses, Dosage, Side Effects, Food Interaction and all others data.
MLTA3698A is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis).
| Trade Name | MLTA3698A |
| Generic | Pateclizumab |
| Pateclizumab Other Names | MLTA3698A, Pateclizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here MLTA3698A
